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Background/Introduction
The implantation and exchange of pacemakers and defi-
brillators (ICD) is meanwhile a fully developed method
with very low complication rates. However, patients
with the need for a permanent anticoagulation with war-
farin have a significantly increased risk for bleeding in
the intraoperative and postoperative course
Aims/Objectives
The aim of this study was to evaluate bleeding compli-
cations associated with implantation or replacement of
implantable cardioverter-defibrillators (ICD) in patients
with a ventricular assisted device (VAD) in whom con-
tinuous anticoagulation is required.
Method
A total of 37 patients with a VAD in whom an ICD has
been implanted, explanted or replaced, were retrospec-
tively analyzed.
Results
All ICD related procedures were successfully performed.
There were no procedure-related deaths. Perioperative
anticoagulation was achieved with intravenous heparin,
which was discontinued four hours prior to surgery and
restarted four hours after surgery. The average interna-
tional normalized ratio ± standard deviation (INR ± SD)
was 1.5 ± 0.3, and the mean partial thromboplastin time
(PTT) ± SD was 67.1 ± 23.1 seconds. Platelet inhibition
in 23 patients (62.2%) was achieved with aspirin, and in
14 patients (37.8%) with clopidogrel up to the time of
surgery. The thirty-seven ICD interventions included ten
primary implants (27.0%), twenty-three replacements
(62.2%) and four explants (10.8%). In a follow-up period
of at least three months, a total of nine complications
(24.3%) were attributable to ICD intervention. These
included two conservatively treated hematomas and six
hematomas that required surgical evacuation. There was
no difference in bleeding frequency comparing subcuta-
neous and subpectoral approach. There were no ICD
lead damages or thromboembolic events identified in
the follow-up period.
Discussion/Conclusion
With regards to anticoagulation in VAD patients post-
ICD intervention, the incidence of hematoma was signif-
icantly higher than in non-VAD patients. On the sixth
postoperative day (5.7 ± 4.9), the hematoma followed.
This delayed incidence of bleeding suggests that re-
initiation of warfarin post-ICD intervention in supple-
ment with intravenous heparin represents a vulnerable
period in which the ICD-pocket wound tends to bleed.
An increased incidence of thromboembolic events was
not observed.
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